Esperion Therapeutics (ESPR) Up 12.6% Since Last Earnings Report: Can It Continue?

Original post

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Esperion Therapeutics, Inc. (ESPR): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research